Dexmedetomidine
FDA Approved: * September 19, 2017Pharm Company: * JIANGSU HENGRUI MED
Category: Anesthetic
Dexmedetomidine, sold under the trade name Precedex among others, is an anxiolytic, sedative, and pain medication. Dexmedetomidine is notable for its ability to provide sedation without risk of respiratory depression[citation needed] (unlike other commonly used drugs such as propofol and fentanyl) and can provide cooperative or semi-rousable sedation. Similar to clonidine, it is a sympatholytic drug that acts as an agonist of α2-adrenergic receptors in certain parts of th... [wikipedia]
* May have multiple approval dates, manufacturers, or labelers.Dosage List
Dexmedetomidine Hydrochloride 4 ug/ml Intravenous Injection, Solution
NDC: 0143-9525
Labeler:
Hikma Pharmaceuticals USA Inc.
Dexmedetomidine Hydrochloride 4 ug/ml Intravenous Injection, Solution
NDC: 0143-9526
Labeler:
Hikma Pharmaceuticals USA Inc.
Dexmedetomidine Hcl 100 ug/ml Intravenous Injection
NDC: 0143-9532
Labeler:
West-ward Pharmaceuticals Corp
Dexmedetomidine Hydrochloride 200 ug/50ml Intravenous Injection
NDC: 0338-9555
Labeler:
Baxter Healthcare Company
Dexmedetomidine Hydrochloride 400 ug/100ml Intravenous Injection
NDC: 0338-9557
Labeler:
Baxter Healthcare Company
Dexmedetomidine Hydrochloride 100 ug/ml Intravenous Injection, Solution
NDC: 0781-3297
Labeler:
Sandoz Inc
Dexmedetomidine Hydrochloride 100 ug/ml Intravenous Injection, Solution, Concentrate
NDC: 0781-3353
Labeler:
Sandoz Inc.
Dexmedetomidine Hydrochloride In 0.9% Sodium Chloride In 0.9% Sodium Chloride 4 ug/ml Intravenous Injection
NDC: 0781-3493
Labeler:
Sandoz Inc.
Dexmedetomidine Hydrochloride In 0.9% Sodium Chloride In 0.9% Sodium Chloride 4 ug/ml Intravenous Injection
NDC: 0781-3494
Labeler:
Sandoz Inc.
Dexmedetomidine Hydrochloride In 0.9% Sodium Chloride In 0.9% Sodium Chloride 4 ug/ml Intravenous Injection
NDC: 0781-3495
Labeler:
Sandoz Inc.
